Methicillin-resistant Staphylococcus aureus infections.

Methicillin-resistant Staphylococcus aureus (MRSA) is an increasingly common multidrug-resistant clinical pathogen responsible for increasing health costs and for patient morbidity and mortality. Presented in this review, the definition, cell and molecular biology, epidemiology, prevention, diagnosis, and treatment of MRSA infections, including skin and soft tissue infections, bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system infections, are addressed. In the treatment of MRSA, this article highlights several common antibiotics that retain activity against different strains of MRSA.

[1]  M. Jackson,et al.  Management of multidrug-resistant organisms in health care settings, 2006. , 2007, American journal of infection control.

[2]  S. Markwell,et al.  Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. , 2010, Annals of emergency medicine.

[3]  L. McCaig,et al.  Staphylococcus aureus–associated Skin and Soft Tissue Infections in Ambulatory Care , 2006, Emerging infectious diseases.

[4]  M. Goetz,et al.  Serotonin syndrome and linezolid. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Fred C Tenover,et al.  Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. , 2003, The New England journal of medicine.

[6]  S. Boyle-Vavra,et al.  Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. , 2005, The New England journal of medicine.

[7]  Susan K. Johnson,et al.  Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. , 2003, JAMA.

[8]  S. Kaplan.  Implications of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in pediatric patients. , 2005, Infectious disease clinics of North America.

[9]  C. Woods,et al.  Clinical identifiers of complicated Staphylococcus aureus bacteremia. , 2003, Archives of internal medicine.

[10]  E Rubinstein,et al.  Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  S. Madhi,et al.  Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Lee H. Harrison,et al.  Health care-associated invasive MRSA infections, 2005-2008. , 2010, JAMA.

[13]  Herman Goossens,et al.  Current Trends in Rapid Diagnostics for Methicillin-Resistant Staphylococcus aureus and Glycopeptide-Resistant Enterococcus Species , 2008, Journal of Clinical Microbiology.

[14]  D. F. Welch,et al.  Multicenter Evaluation of the Cepheid Xpert Methicillin-Resistant Staphylococcus aureus (MRSA) Test as a Rapid Screening Method for Detection of MRSA in Nares , 2009, Journal of Clinical Microbiology.

[15]  J. Jernigan,et al.  Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997-2007. , 2009, JAMA.

[16]  M. Jackson,et al.  National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006. , 2007, American journal of infection control.

[17]  P. Pancholi,et al.  An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  C. Price,et al.  Controlled Multicenter Evaluation of a Bacteriophage-Based Method for Rapid Detection of Staphylococcus aureus in Positive Blood Cultures , 2013, Journal of Clinical Microbiology.

[19]  R. Chinn,et al.  National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at United States health care facilities, 2010. , 2012, American journal of infection control.

[20]  K. Laupland,et al.  Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  Bruno Hoen,et al.  Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  J. Mingorance,et al.  Evaluation of the BinaxNOW PBP2a assay for the direct detection of methicillin resistance in Staphylococcus aureus from positive blood culture bottles. , 2012, Diagnostic microbiology and infectious disease.

[23]  G. Eliopoulos,et al.  Induction of Daptomycin Heterogeneous Susceptibility in Staphylococcus aureus by Exposure to Vancomycin , 2006, Antimicrobial Agents and Chemotherapy.

[24]  Roberta B Carey,et al.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States. , 2007, JAMA.

[25]  S. Yun,et al.  Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia* , 2010, Critical care medicine.

[26]  J. Macia,et al.  Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid , 2005, Scandinavian journal of infectious diseases.

[27]  H. Chambers,et al.  Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods , 2003, Antimicrobial Agents and Chemotherapy.

[28]  S. Pillai,et al.  Emergence of a Clinical Daptomycin-Resistant Staphylococcus aureus Isolate during Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis , 2006, Journal of Clinical Microbiology.

[29]  R. Wenzel,et al.  Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. , 2008, The Cochrane database of systematic reviews.

[30]  M. Sande,et al.  Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. , 1982, Annals of internal medicine.

[31]  R. Klevens,et al.  Case definition for community-associated methicillin-resistant Staphylococcus aureus. , 2006, The Journal of hospital infection.

[32]  G. Corey,et al.  Ceftaroline: a cephalosporin with expanded Gram-positive activity. , 2009, Future microbiology.

[33]  Richard G Wunderink,et al.  Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. , 2003, Clinical therapeutics.

[34]  B. Cooper,et al.  Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. , 2003, Health technology assessment.

[35]  Roberta B Carey,et al.  Methicillin-resistant S. aureus infections among patients in the emergency department. , 2006, The New England journal of medicine.

[36]  B. Diep,et al.  Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  B. R. Reddy,et al.  Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. , 1991, Annals of internal medicine.

[38]  L. Strausbaugh,et al.  Antimicrobial Therapy for Methicillin-Resistant Staphylococcus aureus Colonization in Residents and Staff of a Veterans Affairs Nursing Home Care Unit , 1992, Infection Control & Hospital Epidemiology.

[39]  Richard Platt,et al.  Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  Jack Brown,et al.  Impact of Rapid Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Testing on Mortality and Cost Effectiveness in Hospitalized Patients with Bacteraemia , 2012, PharmacoEconomics.

[41]  J. Guesdon,et al.  Gene heterogeneity for tetracycline resistance in Staphylococcus spp , 1990, Antimicrobial Agents and Chemotherapy.

[42]  R. Wunderink,et al.  Drotrecogin Alfa (activated) Improves In-hospital and 90-day Survival in Patients With Severe Sepsis and Community-acquired Pneumoni , 2003 .

[43]  C. Tuazon,et al.  Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  M. Mete,et al.  Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection. , 2010, Annals of emergency medicine.

[45]  Fred C Tenover,et al.  Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. , 2006, The Journal of infectious diseases.

[46]  R. Wunderink,et al.  Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. , 2003, Chest.

[47]  Brian T. Tsuji,et al.  Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents. , 2007, Diagnostic microbiology and infectious disease.

[48]  J. Ruhe,et al.  Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  K. Edwards,et al.  Increasing Rates of Nasal Carriage of Methicillin-Resistant Staphylococcus aureus in Healthy Children , 2005, The Pediatric infectious disease journal.

[50]  Jack Brown,et al.  Rapid testing for methicillin-resistant Staphylococcus aureus: implications for antimicrobial stewardship. , 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[51]  Sara E Cosgrove,et al.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  J. Patel,et al.  An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[53]  D. Kleinbaum,et al.  Sustained Reduction in the Clinical Incidence of Methicillin-Resistant Staphylococcus aureus Colonization or Infection Associated with a Multifaceted Infection Control Intervention , 2011, Infection Control & Hospital Epidemiology.

[54]  L. Mermel,et al.  Guidelines for the management of intravascular catheter-related infections. , 2001, Infection control and hospital epidemiology.

[55]  B S Cooper,et al.  Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature , 2004, BMJ : British Medical Journal.

[56]  Jerome J. Schentag,et al.  Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[57]  R. Lynfield,et al.  Methicillin-resistant Staphylococcus aureus disease in three communities. , 2005, The New England journal of medicine.

[58]  Paul D. R. Johnson,et al.  Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications , 2010, Clinical Microbiology Reviews.

[59]  L. Friedman,et al.  Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus , 2006, Antimicrobial Agents and Chemotherapy.

[60]  Bruno Hoen,et al.  Staphylococcus aureus endocarditis: a consequence of medical progress. , 2005, Journal of the American Medical Association (JAMA).

[61]  P. Appelbaum.  Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). , 2007, International journal of antimicrobial agents.

[62]  M. Gourlay,et al.  The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[63]  Mian Cai,et al.  Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[64]  T. Maurer,et al.  Randomized, Double-Blind, Placebo-Controlled Trial of Cephalexin for Treatment of Uncomplicated Skin Abscesses in a Population at Risk for Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection , 2007, Antimicrobial Agents and Chemotherapy.

[65]  Marin H Kollef,et al.  New antimicrobial agents for methicillin-resistant Staphylococcus aureus. , 2009, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[66]  D. Raveh,et al.  Risk factors for Clostridium difficile toxin-positive nosocomial diarrhoea. , 2006, International journal of antimicrobial agents.

[67]  S. Cosgrove,et al.  Management of methicillin-resistant Staphylococcus aureus bacteremia. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[68]  Elizabeth Weekes,et al.  Addition of Rifampin to Standard Therapy for Treatment of Native Valve Infective Endocarditis Caused by Staphylococcus aureus , 2008, Antimicrobial Agents and Chemotherapy.

[69]  Mary Jane Ferraro,et al.  Linezolid resistance in a clinical isolate of Staphylococcus aureus , 2001, The Lancet.

[70]  A. Fraise,et al.  Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. , 2006, The Journal of antimicrobial chemotherapy.

[71]  P E Ochsner,et al.  Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. , 1998, JAMA.

[72]  M. Loeb,et al.  Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. , 2003, The Cochrane database of systematic reviews.

[73]  I. Nachamkin,et al.  Use of BBL CHROMagar MRSA Medium for Identification of Methicillin-Resistant Staphylococcus aureus Directly from Blood Cultures , 2006, Journal of Clinical Microbiology.

[74]  Jerome J. Schentag,et al.  The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. , 2005, Archives of internal medicine.

[75]  H. Boucher,et al.  Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[76]  R. Raz,et al.  A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection. , 1996, Archives of internal medicine.